gip glp 1 tirzepatide Effects of tirzepatide, a dual and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Understand GLP-1/GIP Dual Agonist Tirzepatide

Drug Discov Today

Larger randomized controlled trials with clinical endpoints, focusing on both cardiovascular morbidity and mortality, should be performed to verify the cardioprotective properties of GLP-1R agonists in patients with CAD and select the population in whom it will be most effective

With these steps (Tables 3 and 4), the potential of GLP-1 RAs to improve teen health can be maximized while mitigating risks

You can read the abstract of this article at 679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes | Diabetes | American Diabetes Association (diabetesjournals.org)

Researchers identified adults who used GLP-1 receptor agonists and DPP-IV inhibitors and obtained the duration of use in the 6 years before the lag time